Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Jacobs Bruce N.
Chief Financial Officer at Kymera Therapeutics. Filing since 3 Mar 2021.
CIK 0001821074
Company
Date
Role
Action
Shares
Amount
Of holding
KYMR
Kymera Therapeutics, Inc.
30 Jun 2026
Chief Financial Officer
Sold on a plan
77,109
$8.86M
23.9%
KYMR
Kymera Therapeutics, Inc.
4 Mar 2026
Chief Financial Officer
Sold at will
4,895
$417.52K
2.1%
KYMR
Kymera Therapeutics, Inc.
2 Mar 2026
Chief Financial Officer
Sold at will
7,576
$673.71K
3.1%
KYMR
Kymera Therapeutics, Inc.
17 Sep 2025
Chief Financial Officer
Sold on a plan
79,220
$3.96M
25.8%
KYMR
Kymera Therapeutics, Inc.
3 Mar 2025
Chief Financial Officer
Sold at will
7,035
$214.22K
3.4%
KYMR
Kymera Therapeutics, Inc.
4 Mar 2024
Chief Financial Officer
Sold at will
3,934
$164.66K
2.7%
KYMR
Kymera Therapeutics, Inc.
2 Mar 2023
Chief Financial Officer
Sold, plan not stated
1,370
$42.47K
1.3%
KYMR
Kymera Therapeutics, Inc.
12 Jan 2022
Chief Financial Officer
Sold, plan not stated
15,000
$777.68K
46.1%
KYMR
Kymera Therapeutics, Inc.
3 Dec 2021
Chief Financial Officer
Sold, plan not stated
10,000
$535.64K
36.3%
KYMR
Kymera Therapeutics, Inc.
3 Sep 2021
Chief Financial Officer
Sold, plan not stated
10,000
$601.18K
58.0%
KYMR
Kymera Therapeutics, Inc.
3 Jun 2021
Chief Financial Officer
Sold, plan not stated
10,000
$468.70K
58.0%
KYMR
Kymera Therapeutics, Inc.
15 Mar 2021
Chief Financial Officer
Sold, plan not stated
8,195
$493.10K
100%
KYMR
Kymera Therapeutics, Inc.
11 Mar 2021
Chief Financial Officer
Sold, plan not stated
1,805
$108.43K
100%
KYMR
Kymera Therapeutics, Inc.
8 Mar 2021
Chief Financial Officer
Sold, plan not stated
10,000
$506.47K
100%
KYMR
Kymera Therapeutics, Inc.
3 Mar 2021
Chief Financial Officer
Sold, plan not stated
20,000
$895.63K
100%
15 decisions on file.
